Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 14 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-49.23 Insider Own2.62% Shs Outstand2.48M Perf Week-15.25%
Market Cap5.13M Forward P/E- EPS next Y-1.52 Insider Trans-5.14% Shs Float2.41M Perf Month-26.86%
Income-6.44M PEG- EPS next Q-1.61 Inst Own1.63% Short Float0.89% Perf Quarter-56.33%
Sales0.00M P/S- EPS this Y92.22% Inst Trans- Short Ratio0.38 Perf Half Y-66.22%
Book/sh7.99 P/B0.26 EPS next Y53.37% ROA-12.74% Short Interest0.02M Perf Year-94.09%
Cash/sh1.38 P/C1.50 EPS next 5Y- ROE-15.28% 52W Range1.98 - 39.00 Perf YTD-50.71%
Dividend Est.- P/FCF- EPS past 5Y73.53% ROI-7.64% 52W High-94.69% Beta1.41
Dividend TTM- Quick Ratio1.21 Sales past 5Y0.00% Gross Margin- 52W Low4.55% ATR (14)0.27
Dividend Ex-Date- Current Ratio1.21 EPS Y/Y TTM94.30% Oper. Margin0.00% RSI (14)30.31 Volatility13.66% 9.88%
Employees9 Debt/Eq0.09 Sales Y/Y TTM- Profit Margin- Recom2.00 Target Price36.00
Option/ShortNo / Yes LT Debt/Eq0.08 EPS Q/Q101.05% Payout- Rel Volume0.21 Prev Close2.20
Sales Surprise- EPS Surprise0.00% Sales Q/Q- EarningsMay 20 Avg Volume57.35K Price2.07
SMA20-20.58% SMA50-27.60% SMA200-58.44% Trades Volume11,818 Change-5.91%
May-22-24 07:00AM
May-20-24 07:00AM
May-16-24 07:00AM
May-15-24 09:52AM
May-10-24 07:55AM
07:00AM Loading…
May-09-24 07:00AM
Apr-29-24 09:00AM
Apr-24-24 07:00AM
Apr-17-24 07:00AM
Apr-15-24 07:00AM
Apr-05-24 09:55AM
Mar-27-24 12:00PM
Mar-18-24 07:00AM
Mar-14-24 08:05AM
07:00AM Loading…
Mar-05-24 07:00AM
Mar-04-24 08:00AM
Feb-13-24 07:00AM
Jan-23-24 07:00AM
Jan-17-24 07:00AM
Jan-04-24 06:00AM
Dec-27-23 11:55AM
Dec-20-23 10:03AM
Dec-18-23 06:00AM
Dec-14-23 09:15AM
Dec-06-23 07:00AM
Dec-05-23 07:00AM
07:00AM Loading…
Oct-10-23 07:00AM
Oct-03-23 07:00AM
Sep-15-23 08:45AM
Sep-14-23 10:43AM
Sep-05-23 07:00AM
Jul-19-23 08:15AM
Jul-13-23 07:00AM
Jul-05-23 07:00AM
Jun-28-23 07:00AM
Jun-27-23 07:00AM
Jun-15-23 11:31AM
Jun-13-23 12:50PM
May-15-23 07:00AM
May-11-23 07:00AM
May-02-23 07:30AM
Apr-25-23 07:00AM
Mar-13-23 08:00AM
Mar-10-23 07:00AM
Mar-09-23 07:00AM
Feb-28-23 07:00AM
Feb-21-23 07:00AM
Feb-13-23 07:00AM
Feb-07-23 07:00AM
Feb-02-23 07:00AM
Jan-31-23 07:00AM
Jan-30-23 07:00AM
Jan-25-23 07:00AM
Jan-24-23 07:00AM
Jan-13-23 04:00PM
Jan-09-23 09:10AM
Jan-05-23 09:45AM
Dec-12-22 07:30AM
Dec-05-22 07:00AM
Nov-30-22 07:00AM
Nov-25-22 05:45PM
Nov-22-22 04:15PM
Nov-21-22 08:00AM
Nov-16-22 07:00AM
Oct-31-22 07:00AM
Oct-11-22 05:30PM
Oct-10-22 07:00AM
Oct-06-22 09:00PM
Sep-28-22 07:00AM
Sep-19-22 07:00AM
Sep-14-22 07:00AM
Sep-07-22 07:00AM
Aug-31-22 07:00AM
Aug-29-22 07:00AM
Aug-25-22 12:00PM
Jul-15-22 08:00AM
May-17-22 07:00AM
Apr-29-22 04:30PM
Apr-27-22 07:00AM
Mar-31-22 08:15AM
Mar-28-22 04:23PM
Mar-22-22 07:00AM
Mar-08-22 07:00AM
Mar-03-22 07:00AM
Mar-02-22 05:00PM
Mar-01-22 07:00AM
Feb-28-22 08:01AM
Feb-07-22 07:30AM
Jan-17-22 10:30AM
Jan-14-22 11:25AM
Entero Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of non-systemic therapies for the treatment of gastrointestinal diseases. The firm is involved in a therapeutic development pipeline populated with multiple clinical stage programs built around its proprietary technologies, such as Niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties, and the biologic Adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients. Its programs include FW-UP, FW-UC, FW-CD, FW-COV, FW-ICI-AC, MS1819, COVID-19 GI infections, and FW-EPI. The company was founded on January 30, 2014 and is headquartered in Boca Raton, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SAPIRSTEIN JAMESChairman and CEOApr 01 '24Sale4.2317473637,105Apr 03 05:14 PM
Romano SarahChief Financial OfficerApr 01 '24Sale4.237531719,111Apr 03 05:13 PM
SAPIRSTEIN JAMESChairman and CEOMar 15 '24Sale4.961,8879,36037,279Mar 19 04:13 PM
Romano SarahChief Financial OfficerMar 15 '24Sale4.961,1205,55519,186Mar 19 04:10 PM
SAPIRSTEIN JAMESChairman, President and CEOJan 12 '24Sale4.2016669739,166Jan 17 04:01 PM
Romano SarahChief Financial OfficerJan 12 '24Sale4.209841220,306Jan 17 04:02 PM
SAPIRSTEIN JAMESPresident and CEOOct 04 '23Sale0.292,76480233,397Oct 06 04:04 PM
Romano SarahChief Financial OfficerOct 04 '23Sale0.291,67648615,800Oct 06 04:05 PM
CASAMENTO CHARLES JDirectorSep 15 '23Sale0.431046,098Sep 18 05:44 PM
CASAMENTO CHARLES JDirectorAug 31 '23Sale0.306,0531,8166,108Sep 05 08:08 PM
SAPIRSTEIN JAMESPresident and CEOJul 03 '23Sale1.543,3495,15736,161Jul 05 04:27 PM
Romano SarahChief Financial OfficerJul 03 '23Sale1.541,9773,04517,476Jul 05 04:28 PM